Overview

Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To investigate the role of L-arginine supplementation in the treatment of DMARDs-refractory moderate to severe rheumatoid arthritis
Phase:
Phase 2
Details
Lead Sponsor:
RenJi Hospital